GSK vs WLK · P/E 13, $103.31B cap vs rev $5.92B
GlaxoSmithKline PLC ADR (GSK) versus Westlake Chemical Corporation (WLK) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Westlake Chemical Corporation (WLK) is a specialty chemicals company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported WLK revenue for 2026-06-30 was $5.92B. Net income was $91.0M. WLK currently screens at market cap $10.70B.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. WLK currently screens at market cap $10.70B.
Not investment advice. Open the GSK and WLK stock pages for the full models.
Not investment advice.